72 related articles for article (PubMed ID: 7648851)
21. Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine.
Zinzani PL; Tani M; Marchi E; Stefoni V; Alinari L; Musuraca G; Gabriele A; Pileri S; Baccarani M
Haematologica; 2004 Mar; 89(3):309-13. PubMed ID: 15020269
[TBL] [Abstract][Full Text] [Related]
22. Cladribine: from the bench to the bedside--focus on hairy cell leukemia.
Greyz N; Saven A
Expert Rev Anticancer Ther; 2004 Oct; 4(5):745-57. PubMed ID: 15485311
[TBL] [Abstract][Full Text] [Related]
23. Cryptococcus neoformans meningitis in a patient with hairy cell leukemia.
Dinçol G; Kahraman R
Am J Hematol; 2006 May; 81(5):387. PubMed ID: 16628737
[No Abstract] [Full Text] [Related]
24. Rituximab: a useful drug for a repeatedly relapsed hairy cell leukemia patient.
Pollio F; Pocali B; Palmieri S; Morabito P; Scalia G; Del Vecchio L; Ferrara F
Ann Hematol; 2002 Dec; 81(12):736-8. PubMed ID: 12483372
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ
Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
[TBL] [Abstract][Full Text] [Related]
26. 2-Chlorodeoxyadenosine: treatment of hairy cell leukemia, chronic lymphocytic leukemia, and lymphocytic lymphoma.
Piro LD
Semin Hematol; 1993 Oct; 30(4 Suppl 6):28-30. PubMed ID: 7908756
[No Abstract] [Full Text] [Related]
27. Histological examination of the extrabulbar segment of the optic nerve in experimental animals after administration of Cladribine.
Kwietniewska M; Stelmasiak Z; Sekita-Krzak J; Visconti J; Czerny K
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):222-6. PubMed ID: 12898843
[TBL] [Abstract][Full Text] [Related]
28. [Hairy cell leukemia, Japanese variant, successfully treated with cladribine].
Miyazaki M; Taguchi A; Sakuragi S; Mitani N; Matsuda K; Shinohara K
Rinsho Ketsueki; 2004 May; 45(5):405-7. PubMed ID: 15199752
[TBL] [Abstract][Full Text] [Related]
29. The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia.
Else M; Osuji N; Forconi F; Dearden C; Del Giudice I; Matutes E; Wotherspoon A; Lauria F; Catovsky D
Cancer; 2007 Nov; 110(10):2240-7. PubMed ID: 17886250
[TBL] [Abstract][Full Text] [Related]
30. Low-dose cladribine for symptomatic hairy cell leukaemia.
Juliusson G; Lenkei R; Tjønnfjord G; Heldal D; Liliemark J
Br J Haematol; 1995 Mar; 89(3):637-9. PubMed ID: 7734367
[TBL] [Abstract][Full Text] [Related]
31. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J
Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043
[TBL] [Abstract][Full Text] [Related]
32. Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98).
Zenhäusern R; Simcock M; Gratwohl A; Hess U; Bargetzi M; Tobler A;
Haematologica; 2008 Sep; 93(9):1426-8. PubMed ID: 18603561
[No Abstract] [Full Text] [Related]
33. [Successful treatment with cladribine for hypoplastic hairy cell leukemia after long-term neutropenia].
Sakai R; Yamazaki E; Sakamoto H; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2005 Nov; 46(11):1187-90. PubMed ID: 16440801
[TBL] [Abstract][Full Text] [Related]
34. Histological examination of the retinal ganglion layer in rabbits after experimental administration of the new immunosuppressive medicine--Cladribine.
Kwietniewska M; Cybulska R; Kwietniewski P; Sekita-Krzak J; Czerny K
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):376-80. PubMed ID: 12898865
[TBL] [Abstract][Full Text] [Related]
35. Systemic vasculitis complicating hairy cell leukaemia treatment with cladribine.
Tousi B; D'Silva R; Papish S
Clin Lab Haematol; 2002 Aug; 24(4):259-60. PubMed ID: 12181031
[TBL] [Abstract][Full Text] [Related]
36. Cladribine (Leustatin). Single-dose treatment for leukemia.
Am J Nurs; 1994 Nov; 94(11):59-60. PubMed ID: 7977509
[No Abstract] [Full Text] [Related]
37. Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.
Else M; Ruchlemer R; Osuji N; Del Giudice I; Matutes E; Woodman A; Wotherspoon A; Swansbury J; Dearden C; Catovsky D
Cancer; 2005 Dec; 104(11):2442-8. PubMed ID: 16245328
[TBL] [Abstract][Full Text] [Related]
38. Ultrastructural changes of retinal ganglion cells in rabbits of New Zealand breed after experimental administration of 2-CDA (Cladribine).
Kwietniewska M; Cybulska R; Kwietniewski P; Sekita-Krzak J; Czerny K
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):381-6. PubMed ID: 12898866
[TBL] [Abstract][Full Text] [Related]
39. Gynecomastia in a case of hairy cell leukaemia--cladribine induced?
Abhyankar D; Saikia T; Advani S
Leuk Lymphoma; 2001 Jun; 42(1-2):243-6. PubMed ID: 11699216
[TBL] [Abstract][Full Text] [Related]
40. Hairy Cell Leukemia and cutaneous involvement.
Ergene U; Ozbalcı D; Işisağ A
Transfus Apher Sci; 2012 Apr; 46(2):231-2. PubMed ID: 22370038
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
